C. Sanllehy

发表

Effects of oophorectomy and hormone replacement therapy on plasma lipids.

C. Castelo-Branco, E. Casals, X. Iglesias, 1993, Maturitas.

Comparative study of a microporous cholestyramine analogue (filicol) and gemfibrozil for treatment of severe primary hypercholesterolemia. Short- and long-term results.

E. Ros, E. Casals, D. Zambón, 1991, Archives of internal medicine.

Effect of apolipoprotein E polymorphism on the serum lipid response to a hypolipidemic diet rich in monounsaturated fatty acids in patients with hypercholesterolemia and combined hyperlipidemia.

E. Ros, E. Casals, D. Zambón, 1995, The American journal of clinical nutrition.

Variation in lipid levels during pregnancy in women with different types of hypertension

E. Gratacós, V. Cararach, E. Casals, 1996, Acta obstetricia et gynecologica Scandinavica.

Plasma lipids, lipoproteins and apolipoproteins in hirsute women

C. Castelo-Branco, E. Casals, A. Fortuny, 1996, Acta obstetricia et gynecologica Scandinavica.

Apolipoprotein E polymorphism and gallstones.

E. Targarona, E. Ros, J. Ribó, 1996, Gastroenterology.

FIRST‐TRIMESTER BIOCHEMICAL SCREENING FOR DOWN SYNDROME WITH THE USE OF PAPP‐A, AFP, AND β‐hCG

J. Grudzinskas, A. Ballesta, A. Borrell, 1996 .

Normal and gestational diabetic pregnancies. Lipids, lipoproteins and apolipoproteins.

C. Castelo-Branco, E. Casals, V. Cararach, 1998, The Journal of reproductive medicine.

Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation.

E. Ros, J. Laguna, E. Casals, 1999, Metabolism: clinical and experimental.

Lack of interaction of apolipoprotein E phenotype with the lipoprotein response to lovastatin or gemfibrozil in patients with primary hypercholesterolemia.

E. Ros, E. Casals, D. Zambón, 1998, Metabolism: clinical and experimental.

Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate.

C. Castelo-Branco, E. Casals, J. Vanrell, 1996, Journal of reproductive medicine.

Postmenopausal hormone replacement therapy with low-dose medroxyprogesterone acetate. Endometrium, plasma lipids, lipoproteins and apolipoproteins.

C. Castelo-Branco, E. Casals, J. Vanrell, 1995, Journal of reproductive medicine.